Net profit of Alembic Pharmaceuticals rose 12.34% to Rs 153.41 crore in the quarter ended September 2024 as against Rs 136.56 crore during the previous quarter ended September 2023. Sales rose 3.33% to Rs 1647.98 crore in the quarter ended September 2024 as against Rs 1594.93 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 1647.98 | 1594.93 | 3 |
| OPM % | 14.52 | 13.03 | - |
| PBDT | 238.06 | 202.20 | 18 |
| PBT | 167.55 | 134.64 | 24 |
| NP | 153.41 | 136.56 | 12 |